Literature DB >> 1420999

Regulation of synovial cell growth: basic fibroblast growth factor synergizes with interleukin 1 beta stimulating phospholipase A2 enzyme activity, phospholipase A2 activating protein production and release of prostaglandin E2 by rheumatoid arthritis synovial cells in culture.

D H Goddard1, S L Grossman, R Newton, M A Clark, J S Bomalaski.   

Abstract

Cytokines have been implicated in the regulation of eicosanoid synthesis and synovial cell proliferation. To further define these mechanisms, we have compared the effects of basic fibroblast growth factor and platelet-derived growth factor on cell growth, prostaglandin E2 (PGE2) production and phospholipase A2 enzyme activity in long-term cultures of synovial cells from rheumatoid arthritis (RA) patients capable of proliferating in serum-free medium. Compared with serum-free medium alone, RA synovial cell growth was significantly enhanced by adding either basic fibroblast growth factor (bFGF) or platelet-derived growth factor (PDGF) to the culture medium. Growing RA synovial cells for 14 days in serum-free medium plus bFGF caused them to spontaneously release significant amounts of PGE2, an effect not seen if cells were grown in serum-free medium alone, or serum-free medium plus PDGF. Enhanced release of PGE2 occurred when arachidonic acid was added to bFGF but not PDGF-treated RA synovial cells, suggesting that bFGF increased cyclooxygenase enzyme activity in these cells. Moreover, phospholipase A2 (PLA2) enzyme activity was found to be significantly greater in RA synovial cells grown for 14 days in serum-free medium containing bFGF alone, or bFGF plus interleukin 1 beta (IL-1 beta) compared with cells grown in either serum-free medium alone, or serum-free medium plus PDGF. Similarly, bFGF plus IL-1 beta-stimulated release of PLA2 activating protein, a novel mammalian phospholipase stimulator found in high concentrations in RA synovial fluid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420999     DOI: 10.1016/1043-4666(92)90081-2

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvant arthritis in the Lewis rat.

Authors:  Z Qu; M Picou; T T Dang; E Angell; S R Planck; C E Hart; J T Rosenbaum
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

2.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Authors:  J R Vane; J A Mitchell; I Appleton; A Tomlinson; D Bishop-Bailey; J Croxtall; D A Willoughby
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

3.  Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.

Authors:  H Kawaguchi; C C Pilbeam; G Gronowicz; C Abreu; B S Fletcher; H R Herschman; L G Raisz; M M Hurley
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

4.  Effect of the cytokines on the prostaglandin E2 synthesis by lens epithelial cells of human cataracts.

Authors:  O Nishi; K Nishi; M Imanishi; Y Tada; E Shirasawa
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

5.  Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.

Authors:  Raquel E Reinbolt; Stephen Sonis; Cynthia D Timmers; Juan Luis Fernández-Martínez; Ana Cernea; Enrique J de Andrés-Galiana; Sepehr Hashemi; Karin Miller; Robert Pilarski; Maryam B Lustberg
Journal:  Cancer Med       Date:  2017-11-23       Impact factor: 4.452

Review 6.  Lipid composition of the cancer cell membrane.

Authors:  Wojciech Szlasa; Iga Zendran; Aleksandra Zalesińska; Mounir Tarek; Julita Kulbacka
Journal:  J Bioenerg Biomembr       Date:  2020-07-26       Impact factor: 2.945

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.